Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine
Information source: University of South Alabama
Information obtained from ClinicalTrials.gov on October 19, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Migraine
Intervention: propranolol (Drug); zonisamide (Drug); topiramate (Drug)
Phase: N/A
Status: Recruiting
Sponsored by: University of South Alabama Official(s) and/or principal investigator(s):
J. I. Lopez, MD, Principal Investigator, Affiliation: University of South Alabama Department of Neurology
Overall contact:
J. I. Lopez, MD, Phone: 251-665-8375, Email: ilopez@usouthal.edu
Summary
The purpose of this study is to determine if there are significant differences in the side
effects related to memory, repetition and recall among these three drugs when used in a
pediatric population.
Clinical Details
Official title: Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine
Study design: Health Services Research, Randomized, Open Label, Active Control, Single Group Assignment, Safety/Efficacy Study
Primary outcome: Record if memory, repetition or recall was impaired by subject during specific time frame on medication.
Eligibility
Minimum age: 8 Years.
Maximum age: 17 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- diagnosis of migraine with and without aura or chronic daily headache as defined by
IHS
- subjects must between the age of 8-17 (inclusive)
Exclusion Criteria:
- diagnosis of tension-type headache or cluster headache
Locations and Contacts
J. I. Lopez, MD, Phone: 251-665-8375, Email: ilopez@usouthal.edu
University of South Alabama Department of Neurology, Mobile, Alabama 36693, United States; Recruiting
Maher Loutfi, MD, Sub-Investigator
Additional Information
Starting date: August 2007
Ending date: July 2011
Last updated: October 21, 2008
|
